Ftse Mib
36.371,67
0,00%
DAX
21.623,08
0,00%
S&P 500
6.039,31
-0,47%
NASDAQ
19.632,32
-0,51%
Bitcoin
104.948,73
1,17%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Coya Therapeutics Inc (COYA) Coya Therapeutics Inc (COYA) Notizie

Coya Therapeutics Inc

COYA
5,85
0,04 (0,69%)
30 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202514:15BWCoya Therapeutics Announces Pipeline Expansion - COYA 303:..
13/1/202514:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202514:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202514:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202414:15BWCoya Therapeutics Provides Enrollment Update of the..
02/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
29/11/202422:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/11/202414:15BWCoya Therapeutics to Participate in a Fireside Chat at the..
20/11/202423:15EDGAR2Form S-3 - Registration statement under Securities Act of..
19/11/202414:15BWCoya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to..
13/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202414:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202414:02EDGAR2Form 8-K - Current report
06/11/202414:00BWCoya Therapeutics Provides a Corporate Update and Reports..
05/11/202423:02EDGAR2Form 8-K - Current report
01/11/202413:15BWCoya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes..
31/10/202421:42EDGAR2Form 8-K - Current report
29/10/202413:00EDGAR2Form 8-K - Current report
29/10/202411:30BWCoya Therapeutics Announces Positive Results of a..
28/10/202413:00BWCoya Therapeutics Announces Conference Call to Report..
23/10/202422:05BWCoya Therapeutics Announces Closing of $10.0 Million Private..
22/10/202415:08EDGAR2Form 8-K - Current report
22/10/202415:00BWCoya Therapeutics Announces $10.0 Million Private Placement
08/10/202415:15BWCoya Therapeutics Chairman and CEO Howard Berman Selected..
24/9/202414:15BWCoya Therapeutics to Participate in Fireside Chat at the..
16/9/202414:15BWCoya Therapeutics Announces Subcutaneously Administered COYA..
03/9/202414:15BWCoya Therapeutics to Present at Upcoming Healthcare..
20/8/202421:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/8/202415:10EDGAR2Form 8-K - Current report
19/8/202415:00BWCoya Therapeutics Promotes Arun Swaminathan Ph.D. to Chief..
12/8/202414:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202414:04EDGAR2Form 8-K - Current report
12/8/202414:00BWCoya Therapeutics Provides a Corporate Update and Reports..
02/8/202414:15BWCoya Therapeutics Announces that Results from a Double-Blind..
31/7/202414:15BWCoya Therapeutics Expands Pipeline and Intellectual Property..
15/7/202412:10EDGAR2Form 8-K - Current report
20/6/202414:15BWCoya Therapeutics Expands Sponsored Research Collaboration..
14/6/202423:01EDGAR2Form S-3 - Registration statement under Securities Act of..
11/6/202414:15BWCoya Therapeutics Announces Publication of ALS Study in..
06/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202414:00EDGAR2Form 8-K - Current report
03/6/202414:15BWCoya Therapeutics Announces Acceptance of Peer-Reviewed..
28/5/202414:15BWCoya Therapeutics Announces Inclusion in the MSCI USA Micro..
22/5/202414:15BWCoya Therapeutics Announces the Completion of a Controlled..
20/5/202423:00EDGAR2Form 8-K - Current report
Apertura: 5,86 Min: 5,6447 Max: 5,94
Chiusura: 5,81

La tua Cronologia

NASDAQ
COYA
Coya Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci